Literature DB >> 112379

Some perspectives on the transfer of cell-mediated immunity by immune-RNA.

S Dray, D P Braun.   

Abstract

Ribonucleic acid extracts of lymphoid cells from immune hosts were used to transfer in vivo and in vitro cell-mediated immune reactivity to a variety of antigens. The in vivo immune responses transferred by RNA included the delayed cutaneous hypersensitivity reaction to fungal and chemically-defined antigens and the tumor-rejection reaction to guinea pig hepatoma antigens. The in vitro immune responses transferred by RNA included macrophage migration inhibition by fungal, chemically-defined, and tumor antigens. The transfer activity of RNA preparations was contained in the 8 s to 18 s species of RNA and was sensitive to RNase but not to DNase or trypsin. Antigen was not detectable in the RNA preparations and appeared to have no role in the transfer activity. Syngeneic, allogeneic, or xenogeneic sources of RNA could transfer immune reactivity. In each system tested, the transfer of cell-mediated reactivity by RNA was specific for the antigen used to sensitize the RNA donor. The potential use of RNA-mediated transfer of immunity is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112379     DOI: 10.1007/bf00211138

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  55 in total

1.  Marked stimulation of lymphocyte-mediated attack on tumor cells by target-directed liposomes containing immune RNA.

Authors:  W E Magee; J H Cronenberger; D E Thor
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701

2.  Tumor-specific antigen solubilized by hypertonic potassium chloride.

Authors:  M S Meltzer; E J Leonard; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

3.  RNA-mediated immunologic depression.

Authors:  M E Colmerauer; L Rumi; F Saal; C D Pasqualini; S L Rabasa
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

4.  Conversion of non-immune spleen cells by ribonucleic acid of lymphoid cells from an immunized rabbit to produce gammaM antibody of foreign light chain allotype.

Authors:  C Bell; S Dray
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

5.  Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity.

Authors:  B S Wang; S R Onikul; J A Mannick
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

6.  Biological and chemical characterization of human histocompatibility antigens.

Authors:  R A Reisfeld; B D Kahan
Journal:  Fed Proc       Date:  1970 Nov-Dec

7.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

8.  Antibody formation initiated in vitro. 3. Antibody formation and allotypic specificity directed by ribonucleic acid from peritoneal exudate cells.

Authors:  F L Adler; M Fishman; S Dray
Journal:  J Immunol       Date:  1966-10       Impact factor: 5.422

9.  Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes.

Authors:  C M Cohen; G Weissmann; S Hoffstein; Y C Awasthi; S K Srivastava
Journal:  Biochemistry       Date:  1976-01-27       Impact factor: 3.162

10.  Surface immunoglobulins of lymphocytes in mouse plasmacytoma. IV. Evidence for the persistence of the effect of plasmacytoma-RNA on the surface immunoglobulins of normal lymphocytes in vivo and in vitro.

Authors:  N Bhoopalam; V Yakulis; D Giacomoni; P Heller
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

View more
  4 in total

1.  Partial characterization of the RNA from LPS-stimulated macrophages that induces the release of chemotactic cytokines by resident macrophages.

Authors:  R A Ribeiro; C A Flores; F Q Cunha; S H Ferreira; F L De Lucca
Journal:  Mol Cell Biochem       Date:  1995-07-19       Impact factor: 3.396

2.  Effect of the calcium phosphate-mediated RNA uptake on the transfer of cellular immunity of a synthetic peptide of HIV-1 to human lymphocytes by exogenous RNA.

Authors:  F L De Lucca; F M Sawan; M A Watanabe; L R de Souza
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

3.  Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaB.

Authors:  Fernando L De Lucca; Valeria S F Sales; Liliana R Souza; Joana M Murad; Maria Angelica E Watanabe
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

4.  Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA.

Authors:  Fernando L De Lucca; Valeria S F Sales; Liliana R Souza; Maria Angelica E Watanabe
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.